| Variables | No. | % |
| Age of patients |
|
|
| <45 years ≥45 | 35 72 | 32.7 67.3 |
| Histopathology |
|
|
| IDC ILC Others | 92 12 3 | 86.0 11.2 2.8 |
| ER status |
|
|
| Negative Positive | 10 97 | 9.3 90.7 |
| PR status |
|
|
| Negative Positive | 19 88 | 17.8 82.2 |
| Her2neu status |
|
|
| Non amplified Amplified | 79 28 | 73.8 26.2 |
| Molecular subtype |
|
|
| Luminal A Luminal B Her2nue Basal | 76 23 5 3 | 71 21.5 4.7 2.8 |
| Lymph nodes status |
|
|
| Negative Positive | 21 86 | 19.6 80.4 |
| LN stage |
|
|
| N0 N1 N2 N3 | 21 32 20 34 | 19.7 29.9 18.6 31.8 |
| Onset of metastasis |
|
|
| At diagnosis After treatment | 44 63 | 41.1 58.9 |
| Menopausal status |
|
|
| Pre-menopause Post-menopause | 61 46 | 57.0 43.0 |
| No. of metastasis site |
|
|
| Multiple Single | 71 36 | 66.4 33.6 |